The Morbidity, Recovery and Survivorship Working Committee provides scientific oversight for studies related to preparative regimens, prevention and treatment of early non-Graft-versus-Host Disease toxicities and supportive care in the early post-transplant period as well as studies regarding issues of long-term survivors of hematopoietic cell transplantation, including clinical and psychosocial effects of transplantation.
Meetings are held annually during the Tandem Meetings | Transplantation & Cellular Therapy Meetings of ASTCT and CIBMTR. Anyone with interest or expertise in the focus area is encouraged to attend.
The TCT® Trademark belongs to the Cardiovascular Research Foundation. ASTCT, CIBMTR, MCW, NMDP, the 2019, 2020, and 2021 TCT Conferences and materials are NOT affiliated with or sponsored by Cardiovascular Research Foundation.